My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 11 709 / DOI: 10.3332/ecancer.2017.709

Policy

The impact of the EU general data protection regulation on scientific research

The use of personal data is critical to ensure quality and reliability in scientific research. The new Regulation [European Union (EU)] 2016/679 of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data [general data protection regulation (GDPR)], repealing Directive 95/46/EC, strengthens and harmonises the rules for protecting individuals’ privacy rights and freedoms within and, under certain conditions, outside the EU territory. This new and historic legal milestone both prolongs and updates the EU acquis of the previous Data Protection Directive 95/46/EC. The GDPR fixes both general rules applying to any kind of personal data processing and specific rules applying to the processing of special categories of personal data such as health data taking place in the context of scientific research, this including clinical and translational research areas. This article aims to provide an overview of the new rules to consider where scientific projects include the processing of personal health data, genetic data or biometric data and other kinds of sensitive information whose use is strictly regulated by the GDPR in order to give the main key facts to researchers to adapt their practices and ensure compliance to the EU law to be enforced in May 2018.

Keywords: privacy, computer security, humans, European Union (EU), translational medical research, biomedical research

Categories:

Regulatory

Loading Article Metrics ... Please wait

Related articles

Special Issue: Close cooperation with Health Technology Assessment expertise is crucial for implementation and ultimately reimbursement of innovations in oncology

Abstract | Full Article | PDF Published: 28 Oct 2016 / DOI: 10.3332/ecancer.2016.686

Policy: Phosphoethanolamine and the danger of unproven drugs

Abstract | Full Article | PDF | Portuguese Published: 17 Oct 2016 / DOI: 10.3332/ecancer.2016.681

Policy: An Association of Cancer Physicians’ strategy for improving services and outcomes for cancer patients

Abstract | Full Article | PDF Published: 05 Jan 2016 / DOI: 10.3332/ecancer.2016.608

Conference Report: Nursing highlights from the 2015 European Cancer Congress (ECCO18–ESMO40), 25–29 September 2015, Vienna: reinforcing multidiscliplinarity

Abstract | Full Article | PDF Published: 04 Nov 2015 / DOI: 10.3332/ecancer.2015.589

Policy: PACE Continuous Innovation Indicators—a novel tool to measure progress in cancer treatments

Abstract | Full Article | PDF Published: 07 Jan 2015 / DOI: 10.3332/ecancer.2015.498



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence